Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmelo Rizzari

Showing results (1-10 of 149) with videos related to

Pageof 15
Sort By:
The Lancet. Oncology|January 21, 2018
Inotuzumab ozogamicin in older patients with acute lymphoblastic leukaemia: premises and promisesCarmelo Rizzari
Blood|March 29, 2014
Shedding light on the asparaginase galaxyCarmelo Rizzari
The Lancet. Oncology|November 10, 2015
Still trying to pick the best asparaginase preparationCarmelo Rizzari
Pediatric Blood & Cancer|June 23, 2009
Tailoring treatment strategy for acute promyelocytic leukemia in low-income countriesCarmelo Rizzari, Andrea Biondi
British Journal of Clinical Pharmacology|May 21, 2025
Reply to: Methotrexate toxicity and glucarpidase: A call for dose optimization. Koppen A, et al. Br J Clin Pharmacol. 2025;91(5):1289-1292 doi:10.1002/bcp.70044Carmelo Rizzari, Stefan Schwartz
Leukemia & Lymphoma|January 15, 2015
Asparaginase pharmacokinetics and implications of therapeutic drug monitoringBarbara Asselin, Carmelo Rizzari
Haematologica|July 20, 2023
Back to the future: the amazing journey of the therapeutic anti-leukemia enzyme asparaginase <i>Erwinia chrysanthemi</i>Wing H Tong, Carmelo Rizzari
Expert Review of Hematology|March 10, 2026
<i>"Per aspera ad astra"</i>: the transformative contribution of glucarpidase to the improved management of delayed methotrexate elimination after high dose therapyNicolò Peccatori, Stefan Schwartz, Carmelo Rizzari
Expert Review of Anticancer Therapy|September 21, 2011
Predictive factors of relapse and survival in childhood acute myeloid leukemia: role of minimal residual diseaseCarmelo Rizzari, Giovanni Cazzaniga, Tiziana Coliva, et al.
Current Opinion in Oncology|February 6, 2013
Optimizing asparaginase therapy for acute lymphoblastic leukemiaCarmelo Rizzari, Valentino Conter, Jan Starý, et al.
Pageof 15

Showing results (1-10 of 149) with videos related to

Sort By:
Pageof 15
The Lancet. Oncology|January 21, 2018
Inotuzumab ozogamicin in older patients with acute lymphoblastic leukaemia: premises and promisesCarmelo Rizzari
Blood|March 29, 2014
Shedding light on the asparaginase galaxyCarmelo Rizzari
The Lancet. Oncology|November 10, 2015
Still trying to pick the best asparaginase preparationCarmelo Rizzari
Pediatric Blood & Cancer|June 23, 2009
Tailoring treatment strategy for acute promyelocytic leukemia in low-income countriesCarmelo Rizzari, Andrea Biondi
British Journal of Clinical Pharmacology|May 21, 2025
Reply to: Methotrexate toxicity and glucarpidase: A call for dose optimization. Koppen A, et al. Br J Clin Pharmacol. 2025;91(5):1289-1292 doi:10.1002/bcp.70044Carmelo Rizzari, Stefan Schwartz
Leukemia & Lymphoma|January 15, 2015
Asparaginase pharmacokinetics and implications of therapeutic drug monitoringBarbara Asselin, Carmelo Rizzari
Haematologica|July 20, 2023
Back to the future: the amazing journey of the therapeutic anti-leukemia enzyme asparaginase <i>Erwinia chrysanthemi</i>Wing H Tong, Carmelo Rizzari
Expert Review of Hematology|March 10, 2026
<i>"Per aspera ad astra"</i>: the transformative contribution of glucarpidase to the improved management of delayed methotrexate elimination after high dose therapyNicolò Peccatori, Stefan Schwartz, Carmelo Rizzari
Expert Review of Anticancer Therapy|September 21, 2011
Predictive factors of relapse and survival in childhood acute myeloid leukemia: role of minimal residual diseaseCarmelo Rizzari, Giovanni Cazzaniga, Tiziana Coliva, et al.
Current Opinion in Oncology|February 6, 2013
Optimizing asparaginase therapy for acute lymphoblastic leukemiaCarmelo Rizzari, Valentino Conter, Jan Starý, et al.
Pageof 15